Institutional shareholders' exits here. Apparently they both received much more than $0.05/sh. Let's ask the third one, Mitsui, how much they received for their shares and the Bioamber patents they handed over last year to LCY. Hint: Not $1.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.